Condition: Paroxysmal Atrial Fibrillation · Persistent Atrial Fibrillation · Sponsor: Boston Scientific Corporation
This is a multicenter, prospective, single-arm, feasibility study to evaluate the safety and effectiveness of the waveforms being delivered using the FARAPULSE PFA System in patients with Paroxysmal Atrial Fibrillation (PAF) and Persistent Atrial Fibrillation (PersAF).
This description comes directly from the study's public registry record.
Brandon Shuler · +1 701 220 1710 · brandon.shuler1@bsci.com
Always discuss trial participation with your own doctor first.
| Klinicki Bolnicki Centar Split | Split, Croatia | Recruiting |
| Na Homolce Hospital | Prague, Czechia | Recruiting |
| Queen Mary Hospital | Hong Kong, Hong Kong | Not Yet Recruiting |
| Taipei Veterans General Hospital-Hospital | Taipei, Taiwan | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07444320